◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2172

MicroPort NeuroScientific Corporation (2172) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-11

MicroPort NeuroScientific Corporation (2172) operates in the Medical Devices industry and is headquartered in Shanghai, China with about 547 employees. Its market capitalization is roughly CNY 5 billion. In the fiscal year ended 2025-12-31, 2172 reported CNY 790M in revenue and CNY 184M in net income.

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices.

Interactive charts & full statements →

2172 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 790MCNY 762MCNY 666MCNY 547M
Gross ProfitCNY 581MCNY 556MCNY 512MCNY 393M
Operating Income (EBIT)CNY 306MCNY 300MCNY 198MCNY 133M
Net IncomeCNY 184MCNY 254MCNY 146M(CNY 22M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2172 Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(CNY 84M)(CNY 90M)(CNY 344M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2172 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 2.1BCNY 2.0BCNY 2.0BCNY 1.8B
Total LiabilitiesCNY 315MCNY 336MCNY 322MCNY 331M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2172 viewer.

Other Companies in Medical Devices

← 2171All “0-9” companies2175 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.